BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,942 | -4.2% | 51,455 | +15.7% | 0.01% | 0.0% |
| Q2 2023 | $2,027 | -94.3% | 44,482 | -94.9% | 0.01% | -95.1% |
| Q1 2023 | $35,447 | -29.3% | 873,928 | -11.1% | 0.12% | -31.3% |
| Q4 2022 | $50,117 | -99.8% | 983,266 | +136.7% | 0.18% | +103.4% |
| Q3 2022 | $22,378,000 | +13.8% | 415,482 | +35.7% | 0.09% | +17.3% |
| Q2 2022 | $19,670,000 | +241.8% | 306,237 | +312.6% | 0.08% | +275.0% |
| Q1 2022 | $5,755,000 | -1.9% | 74,226 | +8.6% | 0.02% | 0.0% |
| Q4 2021 | $5,867,000 | -55.0% | 68,345 | -57.9% | 0.02% | -58.3% |
| Q3 2021 | $13,042,000 | -57.4% | 162,150 | -57.4% | 0.05% | -56.0% |
| Q2 2021 | $30,621,000 | -22.1% | 380,381 | -18.4% | 0.11% | -32.7% |
| Q1 2021 | $39,331,000 | +6.2% | 466,335 | +1.0% | 0.16% | -5.3% |
| Q4 2020 | $37,042,000 | -33.2% | 461,637 | -33.0% | 0.17% | -45.7% |
| Q3 2020 | $55,429,000 | -11.7% | 689,242 | -5.5% | 0.32% | -25.7% |
| Q2 2020 | $62,775,000 | +124.3% | 729,092 | +111.5% | 0.42% | +78.2% |
| Q1 2020 | $27,988,000 | -1.0% | 344,728 | +2.0% | 0.24% | +23.3% |
| Q4 2019 | $28,263,000 | -36.4% | 337,997 | -33.5% | 0.19% | -43.6% |
| Q3 2019 | $44,462,000 | +256.9% | 508,308 | +234.2% | 0.34% | +235.3% |
| Q2 2019 | $12,458,000 | +146.4% | 152,117 | +144.6% | 0.10% | +142.9% |
| Q1 2019 | $5,056,000 | +20.2% | 62,186 | -3.6% | 0.04% | +7.7% |
| Q4 2018 | $4,206,000 | -89.0% | 64,497 | -87.0% | 0.04% | -86.7% |
| Q3 2018 | $38,255,000 | +365.4% | 496,234 | +345.8% | 0.29% | +326.1% |
| Q2 2018 | $8,220,000 | +10.4% | 111,317 | -2.8% | 0.07% | +9.5% |
| Q1 2018 | $7,446,000 | -29.5% | 114,478 | -29.9% | 0.06% | -30.0% |
| Q4 2017 | $10,561,000 | +8.8% | 163,380 | +5.7% | 0.09% | +9.8% |
| Q3 2017 | $9,703,000 | +19.7% | 154,632 | +15.5% | 0.08% | +13.9% |
| Q2 2017 | $8,106,000 | +67.5% | 133,893 | +43.5% | 0.07% | +63.6% |
| Q1 2017 | $4,838,000 | -51.5% | 93,282 | -58.6% | 0.04% | -54.2% |
| Q4 2016 | $9,981,000 | +48.7% | 225,102 | +59.7% | 0.10% | +68.4% |
| Q3 2016 | $6,710,000 | -4.7% | 140,975 | -9.5% | 0.06% | -3.4% |
| Q2 2016 | $7,041,000 | -38.0% | 155,717 | -43.7% | 0.06% | -38.5% |
| Q1 2016 | $11,361,000 | +48.0% | 276,563 | +37.5% | 0.10% | +47.7% |
| Q4 2015 | $7,675,000 | +5.6% | 201,169 | -9.1% | 0.06% | +1.6% |
| Q3 2015 | $7,270,000 | -52.8% | 221,321 | +0.4% | 0.06% | -48.8% |
| Q2 2015 | $15,411,000 | -46.6% | 220,397 | -47.7% | 0.12% | -43.2% |
| Q1 2015 | $28,849,000 | +19.1% | 421,154 | +27.4% | 0.22% | +12.8% |
| Q4 2014 | $24,220,000 | -16.8% | 330,475 | -18.5% | 0.20% | -17.4% |
| Q3 2014 | $29,105,000 | +30.3% | 405,547 | +31.2% | 0.24% | +36.4% |
| Q2 2014 | $22,345,000 | +42.0% | 309,062 | +44.5% | 0.17% | +45.4% |
| Q1 2014 | $15,732,000 | +16.3% | 213,828 | +9.9% | 0.12% | +17.8% |
| Q4 2013 | $13,528,000 | -65.9% | 194,501 | -67.8% | 0.10% | -66.2% |
| Q3 2013 | $39,696,000 | +189.2% | 604,281 | +205.0% | 0.30% | +193.1% |
| Q2 2013 | $13,726,000 | – | 198,148 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |